Skip to main content
Back to Corporate Site
Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
SEC Filings
Governance
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Email Alerts
Contact
Menu
Press Releases
Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
SEC Filings
Governance
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Email Alerts
Contact
Normal
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
April 06, 2021
Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer
March 18, 2021
ADC Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Updates
March 11, 2021
ADC Therapeutics to Host Fourth Quarter and Year-End 2020 Financial Results Conference Call on March 18, 2021
February 25, 2021
ADC Therapeutics to Participate in Cowen 41st Annual Health Care Conference
February 05, 2021
ADC Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day
February 04, 2021
ADC Therapeutics Completes Enrollment in Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma
January 07, 2021
ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S.
January 04, 2021
ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event